Đang chuẩn bị liên kết để tải về tài liệu:
The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Clear cell renal cell carcinoma (ccRCC), the most aggressive renal cancer, is characterized by early lymph node metastases and bad prognosis. Most therapies targeting advanced or metastatic ccRCC are based, as first-line treatment, on the administration of the vascular endothelial growth factor (VEGF) neutralizing antibody termed Bevacizumab. | The immune-checkpoint HLA-G ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma

TÀI LIỆU LIÊN QUAN

Challenges in diagnosis and management of neutropenia upon exposure to immunecheckpoint inhibitors: Meta-analysis of a rare immune-related adverse side effect